A single-chain Fv (scFv) antibody was developed and applied for efficient and specific detection of Bacillus anthracis spores. The antibody was isolated from a phage display library prepared from spleens of mice immunized with a water-soluble extract of the outer membrane of the B. anthracis spore (exosporium). The library (7 ؋ 10 6 PFU) was biopanned against live, native B. anthracis ATCC ⌬14185 spores suspended in solution, resulting in the isolation of a unique soluble scFv antibody. The antibody was affinity purified and its affinity constant (3 ؋ 10 8 ؎ 1 ؋ 10 8 M ؊1 ) determined via flow cytometry (FCM). Preliminary characterization of scFv specificity indicated that the scFv antibody does not cross-react with representatives of some phylogenetically related Bacillus spores. The potential use of scFv antibodies in detection platforms was demonstrated by the successful application of the soluble purified scFv antibody in enzyme-linked immunosorbent assays, immunofluorescence assays, and FCM.Bacillus anthracis spores, the primary infectious agents causing anthrax, are probably the most likely candidates for a biological terrorist assault. Therefore, rapid detection of spores is critical for a timely response and successful treatment of the disease. Various immunoassays based on the high specificity of antibodies have been developed for the rapid detection of several pathogens. Over the past decade, recombinant technology enabled the production of engineered antibody fragments such as Fabs or single-chain Fv (scFv) antibodies. An scFv antibody is a small engineered antibody in which the variable heavy chain and light chain of the antibody molecule are connected by a short, flexible polypeptide linker. Phage display technology enables the presentation of scFv antibody on the phage surface and has been used successfully for the isolation of specific scFv antibodies from animal repertoire libraries via several enrichment cycles.Using scFv antibodies for antigen detection has several advantages. scFv antibodies can be produced in large quantities in bacterial expression systems, with high reproducibility at low cost, and can be manipulated genetically for improved specificity and affinity (5,15,17). The recombinant antibody can also be fused to marker molecules for detection purposes (25). Recombinant antibodies have been developed for treatment of anthrax infection (26) and disease detection in clinical applications (25). However, the use of recombinant antibodies for detection of B. anthracis spores has not been described. In this study, we describe the construction of an scFv antibody and its successful application for B. anthracis spore detection. Bacillus cultures and sporulation. Spores of all strains were produced in SSM sporulation medium, as previously described (6).
MATERIALS AND METHODS
Bacteria. B. anthracis ⌬14185 is a nontoxinogenic, nonencapsulated (ToxImmunization. Female BALB/c mice were immunized subcutaneously with 1 ϫ 10 7 CFU of irradiated (15 min at maximum intensity in a microwave oven) B. ...